Page 2 - Best Liver cancer stage 4 doctors in Turkey: TOP 31 doctors

With over 20 years of surgical experience, Assoc. Dr. Ugur Ekici specializes in advanced laparoscopic and cancer surgery at Medicana Bahcelievler Hospital.

• Specialty training at Şişli Etfal Hospital's General Surgery Clinic
• Expertise in both standard and minimally invasive cancer procedures
• Published research in international medical journals

Associate Professor Dr. Emrah Eraslan specializes in advanced liver cancer treatment, combining extensive experience with a patient-focused approach at Private Koru Ankara Hospital.

• Board-certified in medical oncology with over 12 years of experience
• Trained at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital
• Active in clinical research with multiple publications
• Focuses on personalized treatment plans for complex cases
• Serves at Koru Ankara Hospital with a multidisciplinary team

Professor of Medical Oncology with a focus on gastrointestinal cancers – Dr. Sezer Saglam leads the department at Gayrettepe Florence Nightingale Hospital.

• 20+ years specializing in medical oncology
• Fellowship-trained at Istanbul University Oncology Institute
• Member of ESMO, ASCO, and ENET societies
• Expert in advanced liver cancer treatments

Prof. Sezer Sağlam leads the Medical Oncology Department at Gayrettepe Florence Nightingale Hospital, specializing in liver cancer care.

• Professor in Medical Oncology with extensive training in gastrointestinal oncology
• Member of prestigious societies including ESMO and ASCO
• Over 20 years of experience in medical oncology
• Special focus on liver and gastrointestinal cancers

Dr. Topcu trained at MD Anderson Cancer Center and specializes in liver cancer among other oncology fields. She brings extensive international expertise to her practice at Biruni University Hospital.

• Board-certified in medical oncology with over 15 years of experience
• Member of European Society for Medical Oncology (ESMO)
• Trained at leading cancer centers in USA and Canada
• Specializes in complex gastrointestinal cancers including liver cancer

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.